Enovis Corp. (ENOV) intrinsic value & 10-year financials

Enovis Corp. (ENOV) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 5.2% a year to $2.2B, with an average return on invested capital of -3.7%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$19.59
Market cap
$1.1B
Revenue (FY2025)
$2.2B
Revenue growth (10-yr CAGR)
-5.2%
ROIC (10-yr avg)
-3.7%
Free cash flow (FY2025)
$19.9M

ENOV 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $2.2B -$1.2B -$20.75 $19.9M -50.0% -34.1%
FY2024 $2.1B -$825.5M -$14.93 -$67.2M -36.8% -20.2%
FY2023 $1.7B -$33.3M -$0.61 $12.8M -3.8% -1.2%
FY2022 $1.6B -$13.3M -$0.25 -$161.3M -4.6% -0.7%
FY2021 $3.9B $71.7M $0.46 $251.9M 6.7% 2.3%
FY2020 $3.1B $42.6M $0.31 $187.2M 5.3% 2.9%
FY2019 $3.3B -$527.6M -$3.89 $5.5M 6.1% 4.1%
FY2018 $2.2B $140.2M $1.16 $156.7M 10.8% 5.6%
FY2017 $1.9B $151.1M $1.22 $150.0M 1.5% 0.6%
FY2016 $3.6B $128.1M $1.04 $183.7M 6.5% 4.0%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Enovis CORP is facing top-line stagnation, with revenue contracting over the decade.

Enovis CORP has historically struggled to out-earn its cost of capital, averaging just -3.7% ROIC.

Over the decade, Enovis CORP shows that management has aggressively returned capital to shareholders by retiring 53.7% of outstanding shares.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Enovis CORP is modeled at -5.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.78 per share.

ENOV stock: frequently asked questions

What is the intrinsic value of Enovis Corp. (ENOV) stock?

Graham's formula only works with positive earnings. Enovis Corp. reported diluted EPS of -$20.75 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has Enovis Corp. grown?

Revenue went from $3.6B in fiscal 2016 to $2.2B in fiscal 2025, a compound annual growth rate of -5.2%. Net income was -$1.2B in fiscal 2025.

Does Enovis Corp. generate free cash flow?

Enovis Corp. generated $19.9M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 8 of the last 10 reported years.

What is ENOV's return on invested capital?

Average ROIC over the last 10 fiscal years was -3.7%, and average return on equity was -8.7%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ENOV data come from?

From Enovis Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 6, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar orthopedic, prosthetic & surgical appliances & supplies stocks